ORIC FY 2019 Earnings — ORIC Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ORICORIC Pharmaceuticals, Inc.

$1B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$29M

Net Income

-$27M

EPS (Diluted)

$-1.40

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$94M

Total Liabilities

$6M

Stockholders' Equity

$88M

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$900,000	-11.1%
Operating Income	-$29M	-$22M	-27.7%
Net Income	-$27M	-$21M	-25.8%